Short-course Radiotherapy Followed by Fruquintinib Plus Adebrelimab and CAPOX in the Full Course Neoadjuvant Treatment of Locally Advanced Rectal Cancer: a Multicenter, Single-arm, Open-label Study
Conditions
- Locally Advanced Rectal Cancer
Interventions
- DRUG: Fruquintinib, Adebrelimab, Oxaliplatin, Capecitabine
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborators